BACKGROUND: Treatment of recurrent oropharyngeal cancer is widely thought to have poor outcomes. Justification for treatment, especially in advanced cases, can be difficult. METHODS: A systematic search of MEDLINE, Embase, and Cochrane databases was conducted. Included studies reported specific recurrent oropharyngeal cancer survival data. RESULTS: Twenty-two retrospective studies were included. Pooled 3-year overall survival (OS) was 26% (95% confidence interval [CI] = 22% to 29%; I squared = 40.7%; p = .057). Pooled 5-year OS was 23% (95% CI = 20% to 27%; I squared = 73.9%; p = .000). Surgical treatment was superior to radiation (5-year OS 26% vs 16%, respectively; p < .001). The 5-year OS improved over time: 18% in the pre-2000 cohort; 35% in the mixed pre-2000 and post-2000 group; and 51% in the post-2000 cohort (p < .001). CONCLUSION: Outcomes have improved considerably over the last 2 decades, resulting in approximately 50% overall 5-year survival. Human papillomavirus (HPV) status, patient selection, and improvements in care may explain this.
BACKGROUND: Treatment of recurrent oropharyngeal cancer is widely thought to have poor outcomes. Justification for treatment, especially in advanced cases, can be difficult. METHODS: A systematic search of MEDLINE, Embase, and Cochrane databases was conducted. Included studies reported specific recurrent oropharyngeal cancer survival data. RESULTS: Twenty-two retrospective studies were included. Pooled 3-year overall survival (OS) was 26% (95% confidence interval [CI] = 22% to 29%; I squared = 40.7%; p = .057). Pooled 5-year OS was 23% (95% CI = 20% to 27%; I squared = 73.9%; p = .000). Surgical treatment was superior to radiation (5-year OS 26% vs 16%, respectively; p < .001). The 5-year OS improved over time: 18% in the pre-2000 cohort; 35% in the mixed pre-2000 and post-2000 group; and 51% in the post-2000 cohort (p < .001). CONCLUSION: Outcomes have improved considerably over the last 2 decades, resulting in approximately 50% overall 5-year survival. Human papillomavirus (HPV) status, patient selection, and improvements in care may explain this.
Authors: Andrew F Brouwer; Kevin He; Steven B Chinn; Alison M Mondul; Christina H Chapman; Marc D Ryser; Mousumi Banerjee; Marisa C Eisenberg; Rafael Meza; Jeremy M G Taylor Journal: Cancer Date: 2020-09-05 Impact factor: 6.860
Authors: Anthony R Cillo; Cornelius H L Kürten; Tracy Tabib; Zengbiao Qi; Sayali Onkar; Ting Wang; Angen Liu; Umamaheswar Duvvuri; Seungwon Kim; Ryan J Soose; Steffi Oesterreich; Wei Chen; Robert Lafyatis; Tullia C Bruno; Robert L Ferris; Dario A A Vignali Journal: Immunity Date: 2020-01-07 Impact factor: 31.745
Authors: Sulsal Haque; Vidhya Karivedu; Muhammed K Riaz; David Choi; Logan Roof; Sarah Z Hassan; Zheng Zhu; Roman Jandarov; Vinita Takiar; Alice Tang; Trisha Wise-Draper Journal: Oral Oncol Date: 2018-11-16 Impact factor: 5.337
Authors: John C Hardman; F Chris Holsinger; Grainne C Brady; Avinash Beharry; Alec T Bonifer; Gregoire D'Andréa; Surender K Dabas; John R de Almeida; Umamaheswar Duvvuri; Peter Floros; Tamer A Ghanem; Philippe Gorphe; Neil D Gross; David Hamilton; Chareeni Kurukulasuriya; Mikkel Hjordt Holm Larsen; Daniel J Lin; J Scott Magnuson; Jeroen Meulemans; Brett A Miles; Eric J Moore; Gouri Pantvaidya; Scott Roof; Niclas Rubek; Christian Simon; Anand Subash; Michael C Topf; Kathryn M Van Abel; Vincent Vander Poorten; Evan S Walgama; Emily Greenlay; Laura Potts; Arun Balaji; Heather M Starmer; Sarah Stephen; Justin Roe; Kevin Harrington; Vinidh Paleri Journal: J Natl Cancer Inst Date: 2022-10-06 Impact factor: 11.816
Authors: Susanne Wiegand; G Wichmann; W Golusinski; C R Leemans; J P Klussmann; A Dietz Journal: Eur Arch Otorhinolaryngol Date: 2018-03-27 Impact factor: 2.503
Authors: Sarah M Dermody; Catherine T Haring; Chandan Bhambhani; Muneesh Tewari; J Chad Brenner; Paul L Swiecicki Journal: Curr Treat Options Oncol Date: 2021-02-08
Authors: Elaine O Bigelow; Jonathan Harris; Carole Fakhry; Maura L Gillison; Phuc Felix Nguyen-Tân; David I Rosenthal; Steven J Frank; Suresh G Nair; Houda Bahig; John A Ridge; Jimmy Caudell; Craig Donaldson; Bradley T Clifford; George Shenouda; Michael J Birrer; Yuhchyau Chen; Quynh-Thu Le Journal: Head Neck Date: 2021-11-03 Impact factor: 3.147